Evidence map›Paper›PMID 38416684›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2024

Incipient functional SARS-CoV-2 diversification identified through neural network haplotype maps.

Soledad Delgado, Pilar Somovilla, Cristina Ferrer-Orta, Brenda Martínez-González, Sergi Vázquez-Monteagudo, Javier Muñoz-Flores, María Eugenia Soria, Carlos García-Crespo, Ana Isabel de Ávila, Antoni Durán-Pastor and 7 more

Open access · hybridAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
6.2field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Article
  3. Methods to Characterize Mutant Spectra of RNA Viruses: The Case of SARS-CoV-2.Methods in molecular biology (Clifton, N.J.) · 2026
    Article
  4. SARS-CoV-2 mutant spectrum complexity is an epidemiologically evolvable trait.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  5. Article
  6. Review
  7. Review
  8. Point mutations at specific sites of the nsp12-nsp8 interface dramatically affect the RNA polymerization activity of SARS-CoV-2.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  9. Article
  10. Review
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 6 institutions in 2 countries.

Soledad DelgadoDepartamento de Sistemas Informáticos, Escuela Técnica Superior de Ingeniería de Sistemas Informáticos, Universidad Politécnica de Madrid, Madrid 28031, Spain.
Pilar SomovillaMicrobes in Health and Welfare Program, Centro de Biología Molecular "Severo Ochoa" (CSIC-UAM), Consejo Superior de Investigaciones Científicas, Madrid 28049, Spain.
Cristina Ferrer-OrtaStructural and Molecular Biology Department, Institut de Biología Molecular de Barcelona, Consejo Superior de Investigaciones Científicas, Barcelona 08028, Spain.
Brenda Martínez-GonzálezDepartment of Molecular and Cell Biology, Centro Nacional de Biotecnología, Consejo Superior de Investigaciones Científicas, Madrid 28049, Spain.
Sergi Vázquez-MonteagudoStructural and Molecular Biology Department, Institut de Biología Molecular de Barcelona, Consejo Superior de Investigaciones Científicas, Barcelona 08028, Spain.
Javier Muñoz-FloresGlobal Management Solutions S.L., Torre Picasso, Madrid 28020, Spain.
María Eugenia SoriaMicrobes in Health and Welfare Program, Centro de Biología Molecular "Severo Ochoa" (CSIC-UAM), Consejo Superior de Investigaciones Científicas, Madrid 28049, Spain.
Carlos García-CrespoMicrobes in Health and Welfare Program, Centro de Biología Molecular "Severo Ochoa" (CSIC-UAM), Consejo Superior de Investigaciones Científicas, Madrid 28049, Spain.ORCID 0000-0001-6561-5389
Ana Isabel de ÁvilaMicrobes in Health and Welfare Program, Centro de Biología Molecular "Severo Ochoa" (CSIC-UAM), Consejo Superior de Investigaciones Científicas, Madrid 28049, Spain.
Antoni Durán-PastorDepartment of Molecular and Cell Biology, Centro Nacional de Biotecnología, Consejo Superior de Investigaciones Científicas, Madrid 28049, Spain.
Ignacio GadeaDepartment of Clinical Microbiology, Instituto de Investigación Sanitaria-Fundación Jiménez Díaz University Hospital, Universidad Autónoma de Madrid, Madrid 28040, Spain.
Cecilio López-GalíndezUnidad de Virología Molecular, Laboratorio de Referencia e Investigación en retrovirus, Centro Nacional de Microbiología, Instituto de salud Carlos III, Majadahonda 28222, Spain.
Federico MoranDepartamento de Bioquímica y Biología Molecular, Universidad Complutense de Madrid, Madrid 28040, Spain.
Ramon Lorenzo-RedondoDepartment of Medicine, Division of Infectious Diseases, Northwestern University Feinberg School of Medicine, Center for Pathogen Genomics and Microbial Evolution, Northwestern University Havey Institute for Global Health, Chicago, IL 60611.
Nuria VerdaguerStructural and Molecular Biology Department, Institut de Biología Molecular de Barcelona, Consejo Superior de Investigaciones Científicas, Barcelona 08028, Spain.ORCID 0000-0001-8826-7129
Celia PeralesDepartment of Molecular and Cell Biology, Centro Nacional de Biotecnología, Consejo Superior de Investigaciones Científicas, Madrid 28049, Spain.
Esteban DomingoMicrobes in Health and Welfare Program, Centro de Biología Molecular "Severo Ochoa" (CSIC-UAM), Consejo Superior de Investigaciones Científicas, Madrid 28049, Spain.ORCID 0000-0002-0573-1676
Consejo Superior de Investigaciones Científicas · ESCentro Nacional de Microbiologia · ESHospital Universitario Fundación Jiménez Díaz · ESNorthwestern University · USUniversidad Complutense de Madrid · ESUniversidad Politécnica de Madrid · ES

Funding

Comunidad de Madrid (Community of Madrid) 13-2022-008566Comunidad de Madrid (Community of Madrid) S2018/BAA-4370Fundació la Marató de TV3 (Fundació la Marató) 202136-30Fundació la Marató de TV3 (Fundació la Marató) 202136-31MEC | Instituto de Salud Carlos III (ISCIII) FI19/00119MEC | Instituto de Salud Carlos III (ISCIII) PI13/02269MEC | Instituto de Salud Carlos III (ISCIII) PI21/00139MINECO CTQ2017-87864-C2-2-PMINECO SAF2016-77894-RMinisterio de Ciencia e Innovacion 202220I116Ministerio de Ciencia e Innovacion PID2020-113888RB-I00Ministerio de Ciencia e Innovacion PID2020-117976GB-I00Ministerio de Ciencia e Innovación (MCIN) PID2019-104903RB-100Ministerio de Ciencia e Innovación (MCIN) PID2022-139908OB-I00Ministerio de Ciencia, Innovación y Universidades (MCIU) CA1/RSUE/2021Ministerio de Ciencia, Innovación y Universidades (MCIU) PRE2018-083422
6 · The paper itself

Abstract

Since its introduction in the human population, SARS-CoV-2 has evolved into multiple clades, but the events in its intrahost diversification are not well understood. Here, we compare three-dimensional (3D) self-organized neural haplotype maps (SOMs) of SARS-CoV-2 from thirty individual nasopharyngeal diagnostic samples obtained within a 19-day interval in Madrid (Spain), at the time of transition between clades 19 and 20. SOMs have been trained with the haplotype repertoire present in the mutant spectra of the nsp12- and spike (S)-coding regions. Each SOM consisted of a dominant neuron (displaying the maximum frequency), surrounded by a low-frequency neuron cloud. The sequence of the master (dominant) neuron was either identical to that of the reference Wuhan-Hu-1 genome or differed from it at one nucleotide position. Six different deviant haplotype sequences were identified among the master neurons. Some of the substitutions in the neural clouds affected critical sites of the nsp12-nsp8-nsp7 polymerase complex and resulted in altered kinetics of RNA synthesis in an in vitro primer extension assay. Thus, the analysis has identified mutations that are relevant to modification of viral RNA synthesis, present in the mutant clouds of SARS-CoV-2 quasispecies. These mutations most likely occurred during intrahost diversification in several COVID-19 patients, during an initial stage of the pandemic, and within a brief time period.

Indexed as

COVID-19SARS-CoV-2HaplotypesHumansRNA, ViralViral Nonstructural ProteinsRNA, ViralViral Nonstructural Proteinsclade transitionCOVID-19intrahost evolutionself-organized mapsviral quasispecies

Identifiers

PMID38416684
PMCPMC10927536
OpenAlexW4392242814

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.